C4 Therapeutics to Participate in Upcoming March Conferences
WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in two upcoming March conferences.
- TD Cowen 46
thAnnual Healthcare Conference:
- Management will present and participate in a fireside chat on March 3, 2026, at 11:50 AM ET taking place in Boston, Massachusetts.
- Barclays 28
thAnnual Global Healthcare Conference:
- Management will participate in a fireside chat on March 10, 2026 at 8:00 AM ET taking place in Miami, Florida.
The live webcasts will be available on the Investors section of the company’s website. The archived replays of the webcasts will be available for approximately 90 days following the events.
About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
XRP Price Consolidates as Market Awaits Breakout Signal

Bitcoin Price Prediction: Elon Musk Predicts Huge US Dollar Shock

South Africa Government Draft Could Land You a $60,000 Fine and Five Years in Prison
Aave raises $160 million after $200 million DeFi hack
